Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2SANOFI-AVENTIS CANADA INC

02 1TAKEDA CANADA INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Prescription

Registration Country : Canada

AGALSIDASE BETA

Brand Name : FABRAZYME

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 5MG/VIAL

Packaging : 1.1ML

Approval Date :

Application Number : 2248965

Regulatory Info : Prescription

Registration Country : Canada

Sanofi Company Banner

02

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Prescription

Registration Country : Canada

AGALSIDASE BETA

Brand Name : FABRAZYME

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 35MG/VIAL

Packaging : 7.2ML

Approval Date :

Application Number : 2248966

Regulatory Info : Prescription

Registration Country : Canada

Sanofi Company Banner

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

AGALSIDASE ALFA

Brand Name : REPLAGAL

Dosage Form : SOLUTION

Dosage Strength : 1MG/ML

Packaging :

Approval Date :

Application Number : 2249057

Regulatory Info : Prescription

Registration Country : Canada

blank